Measure Details
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:- Women age 21-64 who had cervical cytology (Pap Test) performed within the last 3 years
- Women age 30-64 who had cervical human papillomavirus (HPV) testing performed within the last 5 years
Additional CMS Guidance: To ensure the measure is only looking for a cervical cytology test only after a woman turns 21 years of age, the youngest age in the initial population is 23.The measure may include screenings performed outside the age range of patients referenced in the initial population. Screenings that occur prior to the measurement period are valid to meet measure criteria.Evidence of hrHPV testing within the last 5 years also captures patients who had co-testing; therefore additional methods to identify co-testing are not necessary.
Measure Parameters
Numerator
Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:- Cervical cytology (Pap Test) performed during the measurement period or the two years prior to the measurement period for women who are at least 24-64 years of age by the end of the measurement period.
- Cervical human papillomavirus (HPV) testing performed during the measurement period or the four years prior to the measurement period for women who are 30 years or older at the time of the test.
Denominator
Women 24-64 years of age with a visit during the measurement period. Exclusions/Exceptions- Exclude women who had a hysterectomy with no residual cervix or a congenital absence of cervix.
- Exclude patients who are in hospice care for any part of the measurement period.
- Exclude patients receiving palliative care for any part of the measurement period.
Elation Workflows
Documenting measure requirements using a Clinical Reminder in a visit note
Clicking Dismiss will dismiss the reminder and the reminder will not appear again until a new visit note draft is opened.
Documenting measure requirements using the Health Maintenance section
Documenting measure requirements from the test results
Documenting exclusions/exceptions
Measure Information
All women are at risk for cervical cancer. In 2020, an estimated 13,800 women were diagnosed with cervical cancer in the U.S., resulting in an estimated 4,290 deaths (National Cancer Institute, 2020). Screening can identify precancerous lesions and can detect invasive cancer early, when treatment is more likely to be successful (American Cancer Society, 2020). Reference: Measure Information from CMSFrequently Asked Questions
What test codes are linked to the Pap Smear and HPV Tests?
The following test LOINC codes qualify for these screenings- Pap Smear - 10524-7, 18500-9, 19762-4, 19764-0, 19765-7, 19766-5, 19774-9, 33717-0, 47527-7, 47528-5
- HPV Test - 21440-3, 30167-1, 38372-9, 59263-4, 59264-2, 59420-0, 69002-4, 71431-1, 75694-0, 77379-6, 77399-4, 77400-0, 82354-2, 82456-5, 82675-0, 95539-3